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A preceding paper (Shreffler & David 
1972) described the detection of three 
intra-H-2 recombinants during mapping 
studies of the Ss serum protein variant sys- 
tem in the mouse. These recombinants 
were of particular interest and importance 
because they localized the Ss locus within 
the complex chromosomal region control- 
ling H-2 antigens. They are also significant 
because of the information they can pro- 
vide regarding detailed localization of de- 
terminants for the various H-2 alloanti- 
genic specificities within the H-2 complex 
and were therefore analyzed serologically 
in rather great detail. This paper presents 
the results of the serological analyses on 
those three recombinants, designated H-201, 
H-Za", and H-2t1, and on a fourth recom- 
binant, H-2th, detected by Stimpfling 
(1965), which was also of particular in- 
terest because of its great similarity to 
H-2'1. 
Materials and Methods 
The three recombinants detected in this 
laboratory are described in the preceding 
paper (Shreffler & David 1972). Recom- 
binants N-201 and H-2al were derived from 
crossing-over between H-2d and H-2k. Re- 
combinant H-2tl was derived from a cross- 
over between H-2al and H-2s. The H-2th 
cross-over derived from the heterozygous 
parent, H-2a/H-25 (Stimpfling 1965). This 
cross-over is carried in Stimpfling's strain 
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Table I 
H-2 recombinant alleles analyzed 
Derived from 
recombination 
fined H-2 types. This panel of H-2 "typc 
strains" and synonyms used in this paper 
are listed in Table 11. The antisera utilized 
in testing for each specificity are given 
under Results, by specificity. 
A.AL H-2al H-2'' / H-Zk 
C3H.OL H-201 H-2d lH-2k 
i\.TL. H-2tl H-2"1/ H-2s 
A.TH H-2th H-2" / H-2' 
B1O.S ( lIC) (Stimpfling & Reichert 1970). 
I t  was included in this study because pre- 
liminary data indicated that it was very 
similar to H-2". The four recombinant 
chromosomes are now carried in congenic 
inbred strains, CSH.OL, A.AL and A.TL, 
described previously (Shreffler & David 
1972), and a new strain, A.TH, which was 
dcrived from a cross to B1O.S ( J R )  and 
produced in exactly the same manner as 
A'I'L. The recombinant alleles and con- 
genic strains are listed in Table I. Some of 
thc studies described herein were carried 
out with the completed inbred strains. 
However, many of the analyses were per- 
formed on stocks derived at  earlier stages 
during the course of inbreeding, which 
wcre homo/ygous for their H-2 alleles, but 
not completely inbred. For the sake of con- 
\.enience and simplicity, the strain desig- 
nations for the completed inbred lines will 
tic used throughout. 
The details of the procedures used in 
producing H-2 antisera have been de- 
scribed (Shreffler et al. 1966). In some 
cases antisera obtained from the Trans- 
plantation Immunology Branch, National 
Institutes of Health, were used. The cri- 
teria for selection of antisera for each H-2 
cpccificity, the methods for evaluation of 
the specificity of each antiserum, and the 
controls employed in all analyses were as 
dcscribed previously (Shreffler et al. 1966). 
All antisera were analyzed on a panel of 
inbred strains representing all of the de- 
Table I I  
H-2 type strains 
I I 

























HTI/Sf HT I 
(C3H/JSf x JK/St)F, CJ 
C3H/JSf C3H 
AKRISnS f-H-2"' A K R M  
(C57BId/1OJSf x F/St)F, HP 
C3 H/JSf-H-Zoh C3H.OH 
P/JSf P 
DBA/l JSf D1 




The PVP hemagglutination method, 
used for direct tests, and the absorptions 
in vitro and in uiuo were performed as de- 
scribed in a previous paper (Shreffler et al. 
1966). Unless otherwise stated, all dircct 
tests and titrations were done by PVP 
hemagglutination. Antigenic specificities 32 
and 33 were detected by a simple micro- 
cytotoxic test, modified from that described 
by Amos et al. (1969). Lymphoid cells 
were obtained by teasing the axial and 
mesenteric lymph nodes with forceps. The 
cells were washed and suspended in Hank's 
solution at a concentration of 2X 10G/ml. 
The test was carried out in microtiter 
plates (Falcon Plastics, Los Angeles, Calif.) 
with one lambda each of the cell suspen- 
sion, an  appropriate dilution of the anti- 
serum, and undiluted rabbit complement 
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Reciprocal of titer after absorption in 
A,TH 1310 A.AL C3H.01, A.TL 
which had been absorbed with mouse tis- 
sues. A normal serum control was em- 
ployed with each cell suspension. At the 
completion of the test 0.3 'j% trypan blue 
was added and the percentage of stained 





Serological analyses were carried out for 
20 of the defined H-2 specificities. Appro- 
priate antisera were not available for spe- 
cificities 10,14,22,25,27,28,29, nor were 
they available at  the time of these studips 
for the new specificities recently describcd 
by SneII et al. (1971) and Demant et al. 
( 197 1 a, 197 l b )  . Each of the spcicificitics 
analyred will be considered in numerical 
order below. 
H-2.1 - Antiserum (C3H.SWXBlO.M) 
anti-CSH.NB was used to test for H-2.1. 
(This serum was obtained from the Nation- 
al Institutes of Health, Transplantation 
Immunology Branch.) This combination 
differs from that originally used to definr 
H-2.1 [(C57XD2) anti-A (Amos 1962)], 
so the specificity may not be precisely thp 
same. By direct hemagglutination test all 
four recombinants reacted strongly. On in 
viuo absorption, all four recombinants ah- 
sorbed the reactivity of this serum agaimt 
strain A erythrocytes, hence all four arr  
classified as positive for H-2.1. Recently, 
however, Snell et al. (197 1 )  have su17- 
divided H-2.1-positive strains into 1 -corn- 
plete and 1-intermediate classes. Since our 
data do not permit such subclassification, 
further analyses for this distinction will br 
nccrssary. I t  should be noted, however, 
that Snell et al. classified H-2'' and H-2("' 
(which is very similar to H-20') as 1 -inter- 
mediate. 
H-2.2 - The antiserum employed was 
(B10.D2 X A) anti-B1O.A (2R) ,  obtained 
from the National Institutes of Health, 
Transplantation Immunology Branch. Tests 
on our panel showed it specific for H-2.2. 
All four recombinants were consistently 
negative with this antiserum on direct 
hemagglutination test and failed to absorb 
(in v i m )  the reactivity of this antiserum 
against R 10 (H-2.2-positive) erythrocytes. 
H-2.3 - Since all four parental alleles 
determine H-2.3, the presence of this spe- 
cificity was expected in all of the recom- 
binants analyzed. The antiserum employed 
was (R1OXA.CA) anti-A.SW, which con- 
tained anti-H-2.3 and anti-H-2.19. All 
four recombinant cell types reacted with 
thi\ antiserum on direct test. However, as 
shown later, A.TL and A.TH are positive 
for H-2.19, so absorption analysis was ne- 
cessary to test for H-2.3. This is shown in 
Table 3. After in uiuo absorption, all €our 
recombinants absorbed completely the re- 
action against cells for D2, D1, C3H and 
CSH.OH, indicating that all four have 
H-2.3. (A 24-hour in uivo absorption was 
Tabie III 
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Reciprocal of titer after ahsorption in 
P A A.AL C3H.OL A.TI. A.TH 
necessary for clearance by C3H.OL.) Not(. 
also that A.TL and A.TH absorbed the 
reaction with A.SW cells as well, indicat- 
ing that these two recombinants are 
H-2.19-positive. 
Recent data of Demant et al. (1971b) 
have led these authors to subdivide speci- 
ficity H-2.3 into a “family” of apparently 
related specificities, some of which were 
given new symbols. We also have data on 
the heterogeneity of H-2.3, especially as it 
relates to the C3H.OL recombinant strain. 
These data will be presented in a more 
comprehensive future paper. However, the 
present data clearly show that all four 
recombinants are positive for H-2.3 as it 
was originally defined (Hocker et al. 1954). 
H-2.4 - Antiserum (BIOXAKR.M) 
anti-A was employed. This serum could 
also contain anti-H-2.10, but tests against 
the panel revealed no detectable anti-10. 
O n  direct hemagglutination test, this anti- 
serum reacted very strongly with A.AL, 
A.TL and A.TH and failed to react with 
C3H.OL. The results of an in vivo absorp- 




A.AL, A.TL and A.TH are H-2.4-positive, 
while C3H.OL is 4-negative. 
H-2.5 - By direct hemagglutination, all 
four recombinants were strongly positive 
with antiserum (B10.D2 X HTG) anti-B10. 
This antiserum contains only anti-H-2.5 
and anti-H-2.33. Since the four recom- 
binants lack 33 (see below), this reaction 
must be due to anti-5. All four recornbi- 
nants absorbed completely (in v i m )  the 
reactivity of this serum with A cells ( + 5 ,  
H-2.6 - At the time of these studies, a 
C3H anti-P serum was the only antiserum 
available which could be used for the de- 
tection of anti-6. (Because it is impossible 
to produce a monospecific anti-6 in any 
strain combination and because anti-6 
titers are highly variable, relatively few 
antisera are useful for this specificity.) 
C3H anti-P could also contain anti-7 and 
anti- 16. Absorption with the panel revealed 
anti-16, but no anti-7. O n  direct hemag- 
glutination test, A.AL, A.TL, and A.TH 
were positive, and C3H.OL was negative. 
An in viva absorption analysis (Table IV) 
-33). 
showed that C3H.OL removed no activity 
for either P ( + 6 ,  + 16) or A (+6, - 16),  
while A.AL, A.TL and A.TH absorbed for 
A, but not for P. This result indicates that 
A.AL, A.TL and A.TH are +H-2.6, 
- H-2.16, while C.3H.OL is apparently 
-H-2.6, -H-2.16. (Absence of H-2.16 
in C3H.OL is based only upon failure of 
the antiserum to react in direct test, how- 
ever. Since C3H.OL lacks H-2.6, the re- 
maining activity for P, after absorption in 
C3H.OL, could be due to anti-6 plus anti- 
16, or to anti-6 only.) 
H-2.7 - Antiserum (AXBlO.D?) anti- 
BIO.M (kindly provided by Dr. George D. 
Snell) contained anti-H-2.7 and anti- 
H-2.9, ba?,ed upon tests with the panel. 
This antiserum was negative by direct test 
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Test 
cells 
with all four recombinants. O n  in uivo ah- H-2.8 - Antiserum (BlOXASW) anti- 
Forption, none of the recombinants re- A.CA contains both anti-H-2.8 and anti- 
moved reactivity with cells of strain P H-2.9. By direct hemagglutination, it was 
(4-7 ,  -9) or A S W  ( f 7 ,  -9) .  There- positive with A.AL and CSH.OH, but 
fore, all four recombinants must be H-2.7- negative with A.TL and A.TH. The  rc- 
negative. sults of in  uiuo absorption with this serum 
Table V 
Absorption in vivo of anti-H-2.8,9, (RIO x A.SU7) anti-A.CA 
Reciprocal of titer after absorption in Relevant H-2 
n1o D1 I A.AL I C3H.OH I A.TL 1 A.TH specificities 
are shown in Table V. These indicate that 
A.AL and C3H.OH are fH-2.8, while 
A.TL and A.TH are -H-2.8. 
H-2.9 - Antiserum A.SW anti-A.CA, 
containing anti-8, 9 and 27, was absorb- 
ecl in uitro with A tissues to remove anti-8 
arid anti-27. The  absorbed serum failed to 
react with cells from any of the four re- 
combinants, and the reactivity of this se- 
rum with A.CA ( + 9 )  cells was not ab- 
sorbed by the recombinants. It is therefor? 
concluded that all four are H-2.9-negative. 
H-2.11 - Tests against the panel of H--2 
type strains indicated that antiserum (D2 
XBF) anti-CR was specific for H-2.11. 
Although anti-18 could have been present, 
it was not detected. O n  direct hemag- 
glutination tests, this antiserum reacted 
strongly with erythrocytes of strain A.AL, 
but not of CSH.OL, A.TL or A.TH. I n  
v i m  absorption results confirmed the con- 
clusion that A.AL is H-2.11-positive, while 
the other three recombinant types are 
H-2.11-negative. 
H-2.13 - Recombinants A.AL, A.TL 
and A.TH all reacted positively with anti- 
serum (C3HXB10) anti-D1, while 
C3H.OL was negative. This antiserum 
contained anti-17 and anti-30 as well as 
anti-13. However, as shown below, all four 
recornbinant strains are - 17, -30, so the 
reaction must have been due to anti-13. 
This was confirmed in in vivo absorption 
analyses, in which A.AL, A.TL and A.TH 
absorbed reactivity for A and D2 cells 
( + 13, - 17, - 30), while C311.OL did 
not. 
H-2.16 - All four recombinants lack this 
specificity, as shown by the results present- 
cd for H-2.6. 
H-2.17 - An analysis with the H-2 pa- 
nel showed that only anti-H-2.17 was pre- 
sent in serum (B1OXAKK.M) anti-D1. 
This serum failed to agglutinate erythro- 
cytes from any of the four recombinant 
types, and on in  uivo absorption there wa5 
no reduction in activity for D1  cells by any 
of the recombinants, so all four are clas- 
sified as H-2.17-negative. 
11-2.18 -Antiserum C3H anti-C3H.RIII 
is apparently a monospecific anti-18. The  
four recombinant strains were negative 
with the reagent, both by direct tests and 
by in uiuo absorption, so are H-2.18-nega- 
tive. 
H-2.19 - For this specificity, an  anti- 
w u n i  (C57BL/6JXA/J) anti-A.SW was 
employed. This could contain anti-7 and 
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Test 
cells 
anti-19, but in this serum, comprised prc- 
dominantly of early bleedings after immu- 
ni/;ation, no anti-7 was ever detectable, e g .  
the serum was consistently negative against 
A.CA and P cells. O n  direct tests, A.TL 
and A.TH were positive, while A.AL and 
C3H.OL were negative. The  results of a n  
in vivo absorption analysis showed clearly 
that A.TL and A.TH are + 19, A.AL and 
C3H.OL are - 19. 
H-2.23 - This specificity was rather re- 
cently rediscovered (see Snell et al. 1971 
for details). It  was detected in these studies 
Reciprocal of titer after absorption in Relevant H-2 
D l 0  1 C3H 1 C3H.OH 1 A.AL )C3H.OL,) .4.TI, 1 A.TH specificities 
by antiserum (HlOXLP.RII1) anti- 
BlO.BR, obtained from the Transplan- 
tation Immunology Branch, National In- 
stitutes of Health. This serum agglutinated 
erythrocytes of A.AL strongly, of C3H.OL 
very weakly, and was negative with A.TL 
and A.TH. I n  the strain combination cm- 
ployed, both anti-23 and anti-32 could bc 
present ; however, anti-32 is usually very 
weak or negative by hemagglutination. Ab- 
sorption results with this antiserum are 
shown in Table VT. They indicate that 
A.AL is 4-23, while C3H.OL, A.TL and 
Tahle VZ 
Absorption in vivo of anti-H-2.23 (BIO x LP.RIZI) anti-B1O.BR 
B10 0 0 0 0 0 0 0 - 
A 80 0 40 0 20 5 20 23 
C3H 40 0 no 0 80 5 20 23, 32 
C3H.OH 0 0 0 0 0 0 0 32 
A.TH are -23. The weak direct hemag- 
glutination with C3H.OL was probably 
duc to anti-32 (see below). 
H-2.30 - Antiserum A anti-Dl contain- 
ed both anti-H-2.17 and anti-H-2.30. Cells 
of the four recombinant types were nega- 
tive with this antiserum. I n  in uivo ab- 
sorption, the four recombinants also failed 
to remove activity against AKK.M test 
cells ( - 17, + 30), so it seems clear that all 
four are H-2.30-negative. 
H-2.31 - The A anti-D2 serum cni- 
ployed was a speciiic anti-31. I t  reacted 
with C3H.OL on direct test, but was nega- 
tive with A.AL, A.TL and A.TH. In vivo 
absorption results confirmed that C3H.OL 
a Percent dead cells. 
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is 13-2.31 -positive, while the other thrvc 
recombinants are H-2.31-negative. 
H-2.32 - This specificity was testcd in 
the microcytotoxic test with antiserum .4 
anti-CSH, a specific anti-32. The results, 
shown inTableVI1, indicate that C3H.OL 
has H-2.32, while A.AL, A.TL and A.'I'H 
lack this specificity. Unfortunately, the 
titrr of this antiserum was too low to per- 
mit confirmation of the direct test result by 
i l l  viuo absorption. 
H-2.33 - The antiserum employed was 
(R10.D2XA) anti-R10.A (5K), obtained 
from the Transplantation Immunology 
Branch, National Institutes of Health. This 
xrum could also contain anti-H-22, but as 
i t  failcd to react with H T G  cells, it ap- 
parently does not. O n  direct cytotoxic 
tcsts. this serum gave about 20 % cyto- 
toxicity with negative control cells and 
with cells of the recombinants, whereas i t  
gave 90 "/c cytotoxicity with B10 cells. Frrr- 
thermore, in viuo absorption in the four 
recombinants removed no reactivity with 
H--2.33-positive cells. It is therefore con- 
cluded that the four recombinant strains 
are H-2.33-negative. 
Discussion 
In  Table VIII, a summary is presented of 
the H-2 alloantigenic specificities found in 
the four recombinants and the distribution 
of these specificities in the parental H-2 
types from which they were derived. Table 
VII I  also includes Ss types reported in the 
preceding paper (Shreffler & David 1972), 
and Slp types from Passmore & Shreffler 
( 1970). Several points are worth noting in 
these results. 
Three different pairs of H-2-identical, 
but Ss-Slp distinctive recombinants have 
now been detected. These are H-2a and 
H-2a1, H-2th and H-2t1, and H-201 and 
H--20h (see Shreffler et al. 1966 for H-2 
type of the latter). The existence of such 
a z 
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H-2 
Chromosonie 
pairs strongly supports the supposition that 
S s S l p  is located in the middle of the H-2 
complex. The apparent identity of H--2" 
and H-Za1 also lends credence to the long- 
held view that H-2a arose as a cross-over 
between H-2d and H-2k. 
It is worthwhile noting that the sero- 
logical properties of the members of these 
pairs seem unaffected by the Ss and Slp 
differences, either quantitatively or quali- 
tatively. Thus, all specificities of H-2a1 ap- 
pear to be as strongly expressed and quali- 
tatively identical to those of H--2a, etc. 
Likewise, as discussed below the serological 




H-2K ss-Slp H--2D 
Thc separations of certain specificities in 
these recombinants permit the genetic de- 
terminants for these specificities to be as- 
signed to defined regions of the H-2 com- 
plex. These assignments were discussed in 
previous publications (Shrefflcr 1965, 
Shreffler 1967, Shreffler 1970), and morc 
recently have been somewhat reinterpreted 
(Shreffler et al. 1970, Klein & Shreffler 
1971). Only a simple summary of the re- 
combinants described in this paper will be 
presented here. I t  is quite clear that the 
H-2 complex is devisible by recombination 
into at least three regions, H-2K, SS-Slp 
and H-2D. O n  the basis of the four re- 
combinants analyzed, the determinants of 
Table IX  
























s s w p o  
4, 6, 13 
32 




4, 6, 13 
4, 6 ,  13 
3 
1 , 3 , 5  
1 , 3 , 5  
1 , 3 , 5  
1 ,  3, 5, 6 
1 ,335  
1 , 3 , 5  
1 , 3 , 5  
a Position with respect to Ss-Slp cannot be determined because both H-2" and H-2s are SshSlp". 
certain H-2 specificities and Ss-Slp types 
can be assigned to these regions, as shown 
in Table IX. The postulated cross-o\er po- 
sition in each recombinant is indicated by 
a vertical bar. The separation of the H-2K 
and H-2D specificities is for the most part 
self-evident. H-2.8 is assigned to H-2K of 
H-2k, H-2al and H-2a because of its loss 
from H-2th and H-2t1 along with H-2.11 
and 23. It  is assigned to H-2K of H-2" 
and H-2"' because of its association with 
H-2.31 in N-2g (cf. Shreffler 1970). The 
problem of assignment of H-2.1, 3 and 5 
to H-2K, H-2D or to separate regions ha5 
been discussed in detail elsewhere (Shreff- 
ler 1970, Shreffler et al. 1970, Klein & 
Shreffler 1971). In  Table IX, these speci- 
ficities are simply listed as unassigned. 
H-2.6 of H-2s cannot be definitively as- 
signed because both H-2a and H-2al also 
have H-2.6 (located in H-2D of these 
chromosomes) and therefore the H-2th and 
H-2" recombinants are not informative on 
the location of H-2.6 in H-2s. 
Snell et al. (1971) and Demant et al. 
( 1971 b) have presented evidence for he- 
terogeneity among specificities H- 2.1, 3 
and 5 of different H-2 types. Included in 
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their investigation was H-20h, which seems 
to be serologically identical to H-201, and 
which demclnstrated an “intermediate” 
form of these three specificities. Earlier 
(Shreffler et al. 1966), the atypical be- 
havior of H-2.3 of H-20h had been noted. 
While the present studies did not under- 
take to define these subtleties in detail, our 
expericence with H-2Ol suggests that it is 
identical to H-20h in the weak and atypical 
properties of its H-2.1, 3 and 5 specifi- 
rities. Further analyses of these differences, 
;is well as for specificities H-2.27, 28 and 
29 and the newly-defined specificities of 
1)emant et al. (1971a, 1971b), must still 
b r  completed. These will be reported at  a 
later time. 
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